إسرائيل دعوا جومڤا انتيبودي يڠ بوليه سمبوهكن ڤساكيت چوۏيد-19
#TTFCovid-19: The Israel Institute for Biological Research (IIBR) claims to have identified an antibody that neutralizes the SARS-CoV-2 coronavirus.
The IIBR has been leading Israeli efforts to develop a treatment and vaccine for the coronavirus, including the testing of blood from those who recovered from Covid-19.
Antibodies in such samples are widely seen as key to developing a possible cure.
The antibody that the IIBR isolated is monoclonal, meaning it was derived from a single recovered cell and is therefore potentially more potent in yielding a treatment.
PETALING JAYA: The Israel Institute for Biological Research (IIBR) claims to have identified an antibody that neutralizes the SARS-CoV-2 coronavirus.
This was revealed by the Israeli Defense Ministry as reported by the Jerusalem Post.
The ground-breaking discovery is said to involve three key parameters:
1. the antibody is monoclonal, new and refined, and contains an exceptionally low proportion of harmful proteins
2. the institute has demonstrated the ability of the antibody to neutralize the novel coronavirus, and
3. the antibody was specifically tested on the aggressive coronavirus.
The Defence Ministry, in a statement, said IIBR appears to be the first institution to achieve breakthrough by meeting all three parameters simultaneously.
“It should be emphasized that this scientific achievement has the potential to progress towards a treatment for corona patients, and that it is not a vaccine for wide use.
“This is an important milestone, which will be followed by a series of complex tests and a process of regulatory approvals.
“This being said, the scientists at the institute believe that the nature of this breakthrough could lead to a shortening of the process, which could span over several months,” the statement read.
The IIBR has been leading Israeli efforts to develop a treatment and vaccine for the coronavirus, including the testing of blood from those who recovered from Covid-19.
Antibodies in such samples are widely seen as key to developing a possible cure.
The antibody that the IIBR isolated is monoclonal, meaning it was derived from a single recovered cell and is therefore potentially more potent in yielding a treatment.
THE THIRD FORCE
NOTA: SAYA MEMBUAT PENGUMUMAN-PENGUMUMAN PENTING DARI MASA KE SEMASA EKSKLUSIF MENERUSI SALURAN TELEGRAM BERIKUT:
